Acral Melanoma — Trials

Acral Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

29 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02875132	Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma	completed	Phase 2	9	Chinese University of Hong KongOTHER	1	Apr 18, 2025	clinicaltrials
NCT02519322	Neoadjuvant and Adjuvant Checkpoint Blockade	completed	Phase 2	53	M.D. Anderson Cancer CenterOTHER	1	Apr 5, 2024	clinicaltrials
NCT00788775